Results 21 to 30 of about 268 (103)

Evaluation of serum markers of the immune response and bone metabolism facilitates early detection of psoriatic arthritis in patients with psoriasis

open access: yesAlʹmanah Kliničeskoj Mediciny, 2021
Relevance: Psoriatic arthritis (PA) is a severe complication of psoriasis, leading to progressive damage to the musculoskeletal system, a decrease in the quality of life and early disability.
Ksenia M. Koreshkova   +1 more
doaj   +1 more source

Mycosis fungoides and Sézary syndrome

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 19, Issue 9, Page 1307-1334, September 2021., 2021
Summary Mycosis fungoides (MF) and Sézary syndrome (SS) are primary cutaneous T‐cell lymphomas (CTCL) with not yet fully understood etiology and pathogenesis. Conceptually, MF and SS are classified as distinct entities arising from different T helper cell subsets. MF is the most common CTCL entity, while SS is very rare.
Constanze Jonak   +3 more
wiley   +1 more source

Profiles of patients with psoriasis for appointment gene-engineering biological therapy — clinical justification

open access: yesVestnik Dermatologii i Venerologii, 2020
Psoriasis is a chronic immune-mediated disease with predominant damage to the skin and musculoskeletal system. This paper describes the clinical manifestations of psoriasis requiring a special therapeutic approach.
Alexander S. Zhukov   +3 more
doaj   +1 more source

EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris – Part 1: treatment and monitoring recommendations

open access: yesJournal of the European Academy of Dermatology and Venereology, Volume 34, Issue 11, Page 2461-2498, November 2020., 2020
Abstract This evidence‐ and consensus‐based guideline on the treatment of psoriasis vulgaris was developed following the EuroGuiDerm Guideline and Consensus Statement Development Manual. The first part of the guideline includes general information on the scope and purpose, health questions covered, target users and strength/limitations of the guideline.
A. Nast   +26 more
wiley   +1 more source

Onychomycosis in Psoriatic Patients with Nail Disorders: Aetiological Agents and Immunosuppressive Therapy

open access: yesDermatology Research and Practice, Volume 2020, Issue 1, 2020., 2020
Psoriasis and psoriatic arthritis are chronic, relapsing, immune‐based diseases. Psoriatic patients may have nail involvement in 50 to 80% of cases, and this may reach 85% in patients with joint disease, in spite of the fact that the relationship between psoriasis and onychomycosis is not well established.
Núbia Carvalho Pena de Oliveira Praeiro Alves   +7 more
wiley   +1 more source

Bone pathology inpsoriatic arthritis

open access: yesНаучно-практическая ревматология, 2007
Objective. To study different variants of osteolysis in pts with psoriatic arthritis (PA) and to reveal their relationship with other clinico-radiological features of joint damage. Material and methods.
V. V. Badokin
doaj   +1 more source

EVALUATION OF THE EFFECTIVENESS OF TOPICAL TREATMENT COMBINATION OF BETAMETHASONE DIPROPIONATE 0.05%/CALCIPOTRIOL MONOHYDRATE 0.005% GEL AND CLOBETASOLE PROPIONATE 0.05% OINTMENT IN PATIENTS WITH PSORIATIC ONYCHODYSTROPHY

open access: yesRussian Journal of Skin and Venereal Diseases, 2019
Psoriatic onychodystrophy is a comorbidity that often occurs in patients with psoriasis, affecting their quality of life. Although success has recently been achieved in the treatment of the cutaneous form of psoriasis, there are few publications about nail therapy with proven effectiveness.
Ivan S. Maximov   +3 more
openaire   +1 more source

Expert consensus on systemic therapy for plaque psoriasis with limited skin involvement in JAPAN: Results from a DELPHI study

open access: yesThe Journal of Dermatology, Volume 52, Issue 1, Page 56-66, January 2025.
Abstract Our objective was to establish consensus on (1) which patients with plaque psoriasis and limited skin involvement (body surface area [BSA] <10%) are suitable for systemic treatment, and (2) a definition of ‘topical therapy failure’. A steering committee refined 13 statements drawn from literature related to the study objectives. An independent
Akimichi Morita   +8 more
wiley   +1 more source

Effect of dimethyl fumarate in patients with plaque psoriasis meeting the upgrade criteria required for moderate‐to‐severe disease classification

open access: yesJEADV Clinical Practice, Volume 3, Issue 5, Page 1518-1528, December 2024.
This non‐interventional study investigated quality of life, effectiveness, and tolerability of dimethyl fumarate (DMF) during routine clinical practice in a patient population with plaque psoriasis meeting the upgrade criteria for moderate‐to‐severe disease.
Sascha Gerdes   +3 more
wiley   +1 more source

Application of therapeutic physical factors in the therapy of psoriatic onychodystrophy

open access: yesRussian Journal of Physiotherapy, Balneology and Rehabilitation
Background: One of the common clinical manifestations of psoriasis is nail plate damage, leading to psoriatic onychodystrophy (PОD). PОD is often accompanied by severe pain syndrome, causing difficulties in wearing shoes or socks and performing daily household tasks, which leads to a decrease in quality of life and contributes to the development of ...
Alesya Yu. Blokina-Mechtalina   +2 more
openaire   +1 more source

Home - About - Disclaimer - Privacy